Clinical Trial Update: Evaluation of Early Bactericidal Activity and Safety in Pulmonary Tuberculosis With WX-081 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating early bactericidal activity and safety of WX-081 in pulmonary tuberculosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• WX-081

Snippet

Sponsor: Shanghai Jiatan Pharmatech Co., Ltd | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED